Cargando…
Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation
BACKGROUND: Red blood cell (RBC) transfusion risks could be reduced if a robust technology for pathogen inactivation of RBC (PI‐RBCs) were to be approved. MATERIALS AND METHODS: Estimates of per‐unit and per‐patient aggregate infectious risks for conventional RBCs were calculated; the latter used pa...
Autores principales: | Kleinman, Steve, Stassinopoulos, Adonis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169855/ https://www.ncbi.nlm.nih.gov/pubmed/26303806 http://dx.doi.org/10.1111/trf.13259 |
Ejemplares similares
-
Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology
por: Sow, Cissé, et al.
Publicado: (2020) -
Cost implications of implementation of pathogen-inactivated platelets
por: McCullough, Jeffrey, et al.
Publicado: (2015) -
Risks and benefits of transfusion for children with severe anemia in Africa
por: Brick, Thomas, et al.
Publicado: (2014) -
Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019) -
Anemia, red blood cell transfusion, and outcomes after severe traumatic brain injury
por: Roberts, Derek J, et al.
Publicado: (2012)